Strides Pharma Science Limited — Board Meeting, 22-05-2025: Outcome of Board Meeting

Strides Pharma has approved consolidated financial results for the quarter and year ended March 31, 2025, backed by a clean audit opinion. A final dividend of Rs. 4 per share (40%) is proposed, subject to shareholder nod. The merger of Strides Alathur Private Limited with the holding company took effect from April 1, 2023, boosting operational synergy. The strategic demerger of the CDMO and Soft Gelatin units is now reflected retrospectively, signaling a sharper business focus ahead.